Depression and Mortality in End-Stage Renal Disease

被引：0
作者：
Nisha Ver Halen
Daniel Cukor
Melissa Constantiner
Paul L. Kimmel
机构：
[1] SUNY Downstate Medical Center,Department of Medicine
[2] George Washington University,undefined
来源：
Current Psychiatry Reports | 2012年 / 14卷
关键词：
Depression; End-stage renal disease; ESRD; Hemodialysis; Survival; Review; Renal disease; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
End-stage renal disease is growing in prevalence and incidence. With technical advancements, patients are living longer on hemodialysis. Depression is the most prevalent comorbid psychiatric condition, estimated at about 25% of end-stage renal disease samples. The identification and assessment of depression are confounded by the overlap between depression symptomatology and uremia. Several recent studies have employed time-varying models and identified a significant association between depression and mortality. Due to the high prevalence of depression and the potential impact on survival, well-constructed investigations are warranted.
引用
收藏
页码：36 / 44
页数：8
相关论文
共 451 条
[1]  
Coresh J(2006)KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease Am J Kidney Dis 47 S1-S146
[2]  
Selvin E(2007)Prevalence of chronic kidney disease in the United States JAMA 298 2038-2047
[3]  
Stevens LA(2005)Unraveling the racial disparities associated with kidney disease Kidney Int 68 914-924
[4]  
Norris KC(2005)Racial disparities in the optimal delivery of chronic kidney disease care Med Clin North Am 89 475-488
[5]  
Agodoa LY(2005)Epidemiology and risk factors for chronic kidney disease Med Clin North Am 89 419-445
[6]  
Powe NR(2004)Hypertension: trends, risks, drug therapies and clinical challenges in African Americans Ethn Dis 14 S2-23-S2-25
[7]  
Melamed ML(2005)Factors influencing reported rates of treated end-stage renal disease Adv Chronic Kidney Dis 12 32-38
[8]  
McClellan WM(2010)The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans J Am Soc Nephrol 21 1422-1426
[9]  
Hollar D(2008)MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis Nat Genet 40 1175-1184
[10]  
Agatston AS(2005)Life after transplantation: new transitions in quality of life and psychological distress Semin Dial 18 124-131
12345678910